Trials / Completed
CompletedNCT03702673
Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults.
Single-Dose, Randomized, Open-Label, 4-Period, 4-Sequence Crossover Study of Three Prototypes of K-877 CR Tablet and Two K-877 Tablets Administered to Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Kowa Research Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
A study to compare the pharmacokinetics of 3 types of K-877 controlled release tablets with a current normal K-877 tablet in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-877 CR Tablet A | K-877 Controlled Release Tablet A |
| DRUG | K-877 CR Tablet B | K-877 Controlled Release Tablet B |
| DRUG | K-877 CR Tablet E | K-877 Controlled Release Tablet E |
| DRUG | K-877 IR Tablet | K-877 Immediate Release Tablet |
Timeline
- Start date
- 2018-10-05
- Primary completion
- 2018-11-20
- Completion
- 2018-11-20
- First posted
- 2018-10-11
- Last updated
- 2018-12-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03702673. Inclusion in this directory is not an endorsement.